Somatostatin is a potent inhibitor of gastric acid secretion. Recently, at least five distinct somatostatin receptor subtypes (SSTR) have been characterized and evaluated using relatively selective peptide analogues of somatostatin. We sought to determine which somatostatin receptor subtypes are involved in peripheral regulation of gastric acid secretion. Fasted, male Sprague-Dawley rats were anesthetized and were implanted with a double-lumen cannula in the stomach. Acid secretion was measured in gastric samples collected every 10 min by backtitration to pH 7. After a 30-min basal period, a 2-h intravenous infusion of pentagastrin (24 μg · kg-1 · h-1 iv) was started. During the second pentagastrin hour, a 1-h intravenous infusion of either vehicle (0.1% canine serum albumin in 0.9% saline) or somatostatin receptor agonists was begun. The somatostatin receptor agonists included peptides with relative specificity for SSTR1-5 (somatostatin-14; 10 nmol · kg-1 · h-1); SSTR2, SSTR3, and SSTR5 [SMS-(201-995); 10 nmol · kg-1 · h-1; SSTR2 (1-1,000 nmol · kg-1 · h-1; SSTR3 (10-1,000 nmol · kg-1 · h-1); and SSTR5 (10-1,000 nmol · kg-1 · H-1), The SSTR2 agonist decreased pentagastrin-stimulated acid secretion dose dependently, from 82 ± 7% of maximum acid output at 1 nmol-kg-1 · h-1 to 4 ± 7% of maximum at 100 nmol · kg-1 · h-1. At 10 nmol · kg-1 · h-1, the SSTR2 agonist inhibited acid secretion (40 ± 7% of maximum) similarly to somatostatin (37 ± 4% of maximum) and SMS-(201-995) (31 ± 4% of maximum). The SSTR2 agonist inhibited acid secretion approximately 10- to 100-fold more potently than either the SSTR3 or the SSTR5 agonist. These results indicate a that somatostatin regulates gastric acid secretion by activation of SSTR2 receptors.
|Original language||English (US)|
|Journal||American Journal of Physiology - Gastrointestinal and Liver Physiology|
|Issue number||1 31-1|
|State||Published - 1995|
ASJC Scopus subject areas
- Agricultural and Biological Sciences(all)